Overview

4.5 out of 5 (22 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Viloxazine was marketed as an antidepressant in Europe for more than 2 decades under an immediate-release formulation before its potential as a treatment for patients with attention-deficit hyperactivity disorder (ADHD) was considered. Viloxazine received its first endorsement in the United Kingdom in 1971 and was subsequently recognized as an antidepressant in several other nations. However, commercial reasons led to its discontinuation in 2002. 

In April 2021, the U.S. Food and Drug Administration (FDA) approved viloxazine extended-release capsules for children and adolescents with ADHD. Research suggests that the mechanism of action of viloxazine is closely linked to inhibiting the reuptake of norepinephrine. Notably, the (S) stereoisomer of viloxazine exhibits 10 times greater potency than the (R) stereoisomer. This activity provides a comprehensive summary of the essential aspects of viloxazine therapy in the clinical setting, including indications, administration, doses, contraindications, mechanism of action, adverse events, and other crucial information relevant to the interprofessional team responsible for managing and treating ADHD in patients.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify viloxazine's pharmacological profile, mechanism of action, and unique properties compared to other ADHD medications.
  • Screen potential candidates for viloxazine therapy by conducting thorough assessments of their medical history, ADHD symptoms, and treatment response to determine suitability.
  • Assess the effectiveness and safety of viloxazine therapy through ongoing patient evaluation and monitoring of ADHD symptoms and potential adverse events.
  • Communicate effectively about the viloxazine treatment's rationale, potential benefits, risks, and expectations to ensure shared decision-making between patients, caregivers, and the healthcare team.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pediatrics: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Justin M. on 2/23/2022

Dr Haresh D. on 3/30/2022

Murchana K. on 9/28/2022

April D. on 10/14/2022

Natalie p. on 1/3/2023

Dr Jagveer S. on 4/9/2023

Cheryl M. on 6/6/2023

Kym D. on 7/6/2023

Sushma B. on 8/5/2023

Kimberly B. on 10/13/2023

Nivetha V. on 11/9/2023

Akshaya K. on 11/19/2023

Nida A. on 11/24/2023

Adithya nikhileshwar B. on 12/23/2023

Kasie C. on 1/25/2024

Joseph S. on 2/12/2024

Jibril Y. on 2/24/2024

Randall L. on 3/11/2024

Ejaz J. on 4/20/2024

Likta N. on 4/13/2024

Malani K. on 4/15/2024

Dr. Neha K. on 4/17/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user